Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-02

Clinical Trial Update: Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hypofractionated irradiation at regional nodal area for breast cancer compared to standard treatment; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ruijin Hospital | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING